James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by James Hardie Industries Plc on May 22, 2018, covering the period ending March 31, 2018. The filing serves as a report of a foreign private issuer and includes exhibits containing the ASX cover, media release, management analysis, presentation, consolidated financial statements, and actuarial reports.
Key Financial Metrics
The provided text contains the cover page, table of contents, forward-looking statements, and exhibit index for the filing. It does not include the actual financial data from the exhibits (such as the Media Release or Consolidated Financial Statements). Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in the source text.
Material Changes
The filing text does not provide specific comparative financial data or details on material changes versus the prior comparable period. The document references that such analysis is contained within the attached exhibits (Exhibit 99.2 and 99.3), which are not included in the input content.
Guidance, Outlook, and Risks
The filing includes an extensive section on forward-looking statements and risk factors. Key areas of uncertainty and risk identified include:
- Asbestos Liabilities: Risks related to prior asbestos manufacturing, contributions to the Asbestos Injury Compensation Fund (AICF), potential shortfalls in the fund, and currency exchange impacts on recorded liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings, as well as compliance with changing tax and environmental laws.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, consumer confidence, and mortgage availability.
- Operational Risks: Costs associated with plant closures or capital projects, raw material supply and costs, and the integration of the Fermacell business.
- Financial Risks: Currency exchange risks, ability to renew credit facilities, and potential tax charges.
The company explicitly states it assumes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the specific revenue and profit figures in the attached "Media Release" (Exhibit 99.2) and "Consolidated Financial Statements" (Exhibit 99.5), as these are not in the cover text.
- Review the "KPMG Actuarial" report (Exhibit 99.6) for updated estimates on asbestos liabilities and AICF funding requirements.
- Confirm the details of the dividend or distribution notification referenced in Exhibit 99.7.
- Assess the impact of currency exchange rates on the company's reported financial position, given the cross-border nature of its operations and liabilities.
- Monitor the status of the Fermacell integration and any associated capital expenditure projects mentioned in the risk factors.